Together we will beat cancer

Donate

Botox for stomach cancer? No, but the research is fascinating

We take a look at science behind widespread but overblown media reports that Botox could be used to treat stomach cancer

Read More

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.

Read More

A bug’s life: H. pylori and stomach cancer

This entry is part 2 of 5 in the series Cancer and Infections

In the next in our Cancer and Infections series, we look at the stomach bug H. pylori and how it’s linked with cancer.

Read More

The link between cancer and infections

This entry is part 1 of 5 in the series Cancer and Infections

Can you catch cancer? The answer is no, but you can pick up an infection that increases the chances of developing certain types.

Read More

Scientists develop a breath test that could detect stomach cancers

A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer.

Read More

Docetaxel significantly increases survival for incurable gastric cancers

Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today.

Read More

Trial launch of urgently-needed combination treatment for oesophago-gastric cancer

Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford. The trial will test an experimental drug from AstraZeneca in patients with advanced oesophago-gastric cancer – a disease for which no well-established standard treatments exist.

Read More

Cancer Research UK launches trial of experimental drug combination for advanced stomach and oesophageal cancer

Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer.

Read More

Cancer Research UK launches groundbreaking research centre in Oxford

A new centre launched today will cement Oxford’s place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country.

Read More

Deprived cancer patients face fatal health problems

Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.

Read More